Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.

25.74 0.25 +0.98%
Market cap
$24.9B
P/E
18.8×
Fwd P/E
11.2×
Dividend yield
3.94%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
17.44 18.53 13.30 18.34 27.57 4.69 0.00 0.00 27.23 24.87
Piotroski F-Score
7 6 7 5 6 4 3 5 5 7
P/S ratio
1.02 1.63 1.16 1.33 1.78 1.34 0.61 0.87 1.22 1.27
Altman Z-Score
2.25 2.93 2.62 3.10 3.07 2.17 1.25 1.61 1.71 1.98
Altman Z″-Score (non-manufacturers)
2.71 3.30 2.81 2.93 2.91 2.64 1.69 1.67 1.70 2.10
P/FCF ratio
23.33 22.97 12.62 14.98 12.69 9.58 0.00 0.00 0.00 44.24
Beneish M-Score
(2.57) (2.85) (2.48) (2.54) (2.88) (2.53) (2.78) (2.90) (2.82) (2.68)
P/Operating CF
23.41 87.62 18.06 24.51 19.99 30.17 37.61 58.01 (267.60) 16.23
Dividend Safety Score
— — — — — — — — — 55
P/B ratio
1.85 2.49 2.33 3.17 3.50 2.04 1.02 1.61 1.84 2.07
Price to Tangible BV
23.66 31.55 0.00 83.41 48.32 195.21 0.00 0.00 0.00 0.00
EV/Sales
1.08 1.75 1.23 1.44 1.89 1.53 0.89 1.14 1.51 1.50
EV/EBITDA
8.34 14.37 7.48 9.49 9.57 8.40 8.00 35.24 17.61 10.50
EV/Operating CF
13.93 15.42 9.39 11.26 9.67 7.31 12.20 21.71 308.66 22.83
EV/FCF
24.71 24.70 13.40 16.31 13.45 10.93 (690.86) (144.01) (23.53) 52.15
Quick Ratio
0.77 0.88 0.80 0.88 0.99 0.85 0.71 0.71 0.84 0.86
Current Ratio
1.34 1.47 1.21 1.36 1.45 1.39 1.29 1.20 1.23 1.32
Net Debt/EBITDA
0.47 0.80 0.45 1.12 0.74 2.17 4.17 4.44 2.42 1.59
Debt/Assets
12.45% 15.97% 13.17% 18.28% 20.59% 20.91% 23.69% 23.92% 24.55% 25.73%
Debt/Equity
0.30 0.34 0.28 0.39 0.48 0.45 0.55 0.58 0.59 0.63
Asset Turnover
0.77 0.62 0.72 0.72 0.72 0.59 0.54 0.61 0.62 0.65
Operating CF/Net income
1.31 1.13 1.63 1.74 2.34 0.49 0.11 (4.58) (2.23) 1.31
Capex/Depreciation
(0.64) (0.66) (0.73) (0.65) (0.56) (0.55) (0.27) (0.44) (0.48) (0.59)
Interest Coverage
3.31 5.77 6.51 7.06 7.56 2.94 (5.92) (0.31) 1.37 4.12
ROE
11.43% 13.13% 9.23% 9.19% 9.78% 25.56% (10.89%) (3.73%) (5.82%) 7.95%
ROA
4.57% 5.82% 4.34% 4.29% 4.38% 11.50% (4.91%) (1.57%) (2.40%) 3.27%
ROIC
7.85% 6.74% 8.02% 6.37% 6.75% 1.86% (4.96%) (0.42%) 1.98% 5.91%
Return on Tangible Assets
25.15% 34.22% 32.62% 21.83% 19.23% 59.31% (32.40%) (11.27%) (16.22%) 19.29%
Average Days of Receivables
81.60 82.48 84.24 88.64 80.46 84.40 88.80 79.41 88.15 73.47
Research and Development Expense of Revenue
8.24% 9.92% 9.71% 9.67% 9.80% 10.53% 11.80% 10.40% 9.69% 9.53%
Selling, General and Administrative Expense of Revenue
27.46% 27.98% 28.32% 27.27% 27.00% 28.31% 29.62% 28.25% 28.12% 27.87%
Intangible Assets out of Total Assets
0.39 0.44 0.46 0.45 0.40 0.46 0.45 0.44 0.46 0.44
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.50% 0.59% 0.63% 0.53% 0.48% 0.53% 0.79%
Graham Net Nets
(0.19) (0.11) (0.15) (0.12) (0.12) (0.22) (0.55) (0.39) (0.34) (0.27)
Graham Number
25.18 26.39 0.00 30.38 26.17 56.46 0.00 0.00 16.63 17.92
Earnings Yield
5.73% 5.40% 7.52% 5.45% 3.63% 21.30% (20.07%) (9.73%) 3.67% 4.02%
Free Cash Flow Yield
4.29% 4.35% 7.92% 6.67% 7.88% 10.44% (0.21%) (0.91%) (5.27%) 2.26%
Revenue per Share
29.55 21.64 23.19 24.16 24.58 22.45 21.30 21.43 20.89 21.28
Operating CF per Share
2.30 2.28 2.28 2.52 3.49 2.13 (0.21) 2.52 1.82 1.40
Capex per Share
(1.00) (0.83) (1.02) (1.21) (1.16) (0.96) (0.94) (0.65) (0.77) (0.79)
Free Cash Flow per Share
1.29 1.44 1.26 1.31 2.33 1.18 (1.15) 1.87 1.05 0.61
Cash per Share
3.06 2.43 2.76 1.77 4.19 3.10 1.56 2.26 2.87 3.43
Shareholders Equity per Share
16.28 14.63 15.50 15.66 14.98 18.94 15.87 14.23 13.96 13.11
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
16.28 14.63 15.50 15.66 14.98 18.94 15.87 14.23 13.96 13.11
Free Cash Flow
1,187.38 1,340.54 1,160.92 1,179.36 2,116.68 1,063.61 (1,012.51) 1,712.20 980.38 580.41
Working Capital
3,985.97 3,674.61 1,923.85 2,778.72 3,988.91 3,427.45 2,449.62 1,789.04 2,030.02 2,741.38
Capital Expenditures
(919.58) (773.13) (941.26) (1,095.36) (1,055.49) (863.66) (830.24) (599.59) (717.43) (745.59)
Net Current Asset Value
(5,223.16) (3,588.70) (5,113.73) (5,523.84) (5,237.45) (7,263.05) (7,529.03) (8,014.43) (7,478.39) (6,813.30)
EV/EBIT
14.09 18.05 16.50 35.22 44.73 37.50 0.00 0.00 16.88 18.79
Capex to Sales
0.03 0.04 0.04 0.05 0.05 0.04 0.04 0.03 0.04 0.04
Price to Operating Income
13.30 16.79 15.54 32.37 42.21 32.86 0.00 0.00 13.62 15.94
Other line items
Depreciation/Fixed assets
0.60 0.65 0.64 0.52 0.62 0.50 1.12 0.51 0.57 0.51
Cash ROIC
5.35% 6.57% 5.55% 5.55% 8.85% 3.86% (4.40%) 7.53% 4.19% 2.47%
Accounts Receivable Turnover
4.63 3.79 4.51 4.26 4.37 4.22 4.06 4.45 4.34 4.60
Accounts Payable Turnover
5.03 3.94 4.45 4.70 5.16 5.10 5.22 5.59 5.47 5.32
Inventory Turnover
4.05 3.38 3.88 3.79 3.77 3.15 2.68 2.88 3.06 3.30
Average Days of Payables
74.76 79.46 87.85 71.89 71.92 68.41 67.56 65.26 65.18 71.95
Days of Inventory on Hand
89.04 89.46 102.01 95.42 101.59 126.08 138.99 118.85 113.90 107.16
Average Receivables
5,861.94 5,303.41 4,740.24 5,118.83 5,108.73 4,806.05 4,631.41 4,423.90 4,493.82 4,385.51
Average Payables
3,059.85 2,756.96 2,541.09 2,529.76 2,380.11 2,317.65 2,144.12 2,074.13 2,027.51 2,080.23
Average Inventory
3,799.45 3,206.59 2,908.80 3,131.88 3,262.33 3,750.30 4,173.86 4,022.17 3,619.43 3,353.84
Average Assets
35,071.13 32,180.03 29,671.00 30,493.18 30,957.24 34,143.26 34,481.42 32,079.50 31,590.52 30,919.69
Average Common Equity
14,014.23 14,268.78 13,949.30 14,223.94 13,867.27 15,360.52 15,559.65 13,524.31 13,043.22 12,731.78

Fold the line items

Columns are period end dates